PharmAust Announces Monepantel Reformulation - Media coverage, page-2

Thanks Mickey

BUT the real article of interest is below that one on PAA. for all the critics that have said maybe the $500m price tag might be a bit steep...check out this one

US-based Varian is seeking a federal court order that will allow shareholders to vote on its proposed $1.6 billion takeover of Australian cancer company Sirtex (ASX:SRX).
The shareholder meeting was originally called to consider Varian's $28 per share bid for Sirtex. Varian submitted the bid in January.
However, the Chinese company CDH Investments formally submitted a $1.9 billion bid for Sirtex last week. Its bid values the company at $33.60 per share.
Varian decided not to match the CDH bid and has taken action in the federal court to ensure a shareholder vote proceeds on its $1.6 billion offer.

Bring it on....